Crohn’s Disease: How HUMIRA Works
You need adobe flash player to watch this video.
In Crohn's disease, excess TNF attacks the intestines
Many patients with Crohn's disease produce too much of a protein called TNF (tumor
necrosis factor) in their body. This excess TNF attacks the intestines and other
parts of the gastrointestinal (GI) tract, and can
cause them to become inflamed. This can result in the pain, diarrhea, and other
symptoms of Crohn's disease.
HUMIRA targets TNF to fight Crohn's disease
HUMIRA belongs to a class of biologics known as TNF blockers. TNF blockers have
a specific target in the body and work by binding the excess TNF to help block the
inflammation that can lead to Crohn's symptoms.
HUMIRA Uses
HUMIRA is a prescription medicine used to reduce signs and symptoms, and to achieve and
maintain clinical remission in adults with moderate to severe Crohn’s disease who have not
responded well to conventional treatments, and in these adults who have also lost response
to or are unable to tolerate infliximab.
HUMIRA has been shown to be effective
In a clinical study more than half of the patients who took HUMIRA had improvement
in their symptoms, versus about 1 out of 3 who took placebo. In the same study,
about 1 out of 3 patients who took HUMIRA achieved remission (absence of symptoms
over a long period of time), versus about 1 out of 10 who took placebo. In another
trial, many similar patients taking HUMIRA started to notice relief of symptoms
in as little as 4 weeks. Patients who don't notice improvement within 12 weeks should
discuss their results with their doctor.
HUMIRA is not right for everyone. While HUMIRA can block the bad effects of TNF,
it also can affect how your immune system normally works and may cause serious side
effects.